期刊文献+

尿Cystatin C在慢性肾脏病中的诊断价值 被引量:3

Value of Application of Urinary Cystatin C for Diagnosing Chronic Kidney Disease
下载PDF
导出
摘要 目的:探讨尿CystatinC在慢性肾脏病(CKD)中的诊断价值。方法:选择2006年12月~2007年12月我院住院CKD患者118例作为病例组,健康体检者20人为对照组,测定尿Cystatin C、24h尿蛋白定量、尿α1-微球蛋白(α1-MG)、尿白蛋白、尿转铁蛋白、尿IgG、血、尿β2-微球蛋白(β2-MG),并检测血清肌酐、白蛋白,计算MDRD-GFR。结果:尿Cys-tatin C与MDRD、血β2-MG、转铁蛋白、尿白蛋白、尿IgG没有相关性(P>0.05);尿Cystatin C与尿β2-MG、α1-MG、24h尿蛋白量有相关性;尿Cystatin C的受试者工作特征曲线下面积(AUCROC)>尿β2-MG的AUCROC。结论:尿Cystatin C不能反映GFR的减退,是肾小管损伤的敏感指标,在反映肾小管损伤方面优于尿β2-MG。 Objective:To evaluate the diagnostic value of urinary Cystatin C in patients with chronic kidney disease(CKD). Methods: Between December 2006 and December 2007,118 patients with CKD from the Department of Nephrology, Shanghai Sixth People's Hospital were? invovled as trial group, while 20 healthy persons were as control group. Urinary cystatin C,24 - hour urine protein, α1 - mieroglohulin( α1 - MG) 、 microalbumin ( MA ) 、 Urinary transferring ( TF), serum and urinary β2 microglobulin ( β2 - MG), urinary IgG concentration were detected, serum creatinine and albumin were detected simultaneously. Estimate Glomerular filtration rate(eGFR) was estimated with equation of MDRD. Results:There was no correlation between urinary cystatin C and MDRD - GFR, Urinary TF, serum β2 - MG, MA, urinary IgG( P 〉 0.05 ). While urinary cystatin C was correlated with urinary β2 - MG, α1 - MG and 24 - hour urine protein;AUCROCof the urinary Cys C was larger than AUCRCof the urinary β2- MG. Conclusion. Urinary Cystatin C does not reflect the decrease of GFR. However, it is a more sensitive marker of tubular dysfunction compared with urinary β2 - microglobulin. KEY WORDS Chronic kidney disease Urinary cystatin C Urinary α1 - MG Urinary β2- MG
出处 《中国中西医结合肾病杂志》 2009年第3期220-222,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 慢性肾脏病 尿Cystatin C 尿Α1-微球蛋白 尿Β2-微球蛋白 Chronic kidney disease Urinary cystatin C Urinary α1-MG Urinary β2-MG
  • 相关文献

参考文献10

  • 1Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biligical fluids. Clinical Nephrology, 1992,38 (Suppl 1 ): S20 - S22.
  • 2National Kidney Foundation. K/DOQ I clinical practice guidelines for chronic kidney disease: evaluation, classification and tratifieation. Am J Kidney Dis, 2002,39(suppl) : S1 - S266.
  • 3Guido F, Arend B, Hofmann W, et al. Cystatin C as a marker of GFR - history, indications, and future research. Clinical Biochemistry,2005,38( 1 ) : 1 - 8.
  • 4方一卿,马骏,沈汉超,鲁盈.血清胱抑素C评价慢性肾脏病患者早期肾损害的临床研究[J].中国中西医结合肾病杂志,2007,8(3):145-148. 被引量:58
  • 5Cepeda FJ, Femdndez E, Pobes A, et al. Utility of cystatin - C in hospitalized patients. Comparing with different methods of assessing renal function. Nefrologia, 2007,27 (2) : 168 - 174.
  • 6Yang YS, Peng CH, Liu CK, et al. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes. Intern Med, 2007,46 (12) : 801 - 806.
  • 7Conti M, Moutereau S, Zater M, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med, 2006,44(3) :288 - 291.
  • 8Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracie surgery. Kidney Int, 2008,74 (8) : 1059 - 1069.
  • 9杨丽,马骏龙,丛玉隆.pH值对尿β_2-微球蛋白测定的影响[J].江西医学检验,2003,21(6):473-474. 被引量:8
  • 10王蕾,刘华,符玉瑛,高锋.尿液贮存温度、时间及pH值对尿半胱氨酸蛋白酶抑制剂C稳定性的影响[J].检验医学,2005,20(3):224-226. 被引量:24

二级参考文献20

  • 1李云生,曾爱平,戴再友,陈晓莉,周仁芳,王焰兵,吴光华.240例肾脏疾病患者血清胱抑素C的变化及临床相关研究[J].中国中西医结合肾病杂志,2004,5(10):598-599. 被引量:29
  • 2郝培良.筛检试验与诊断试验[A].见:郝培良.临床流行病学:第1版[C].上海:上海医科大学出版社,2000.132-152.
  • 3Blumsohn A, Morris BW, Griffiths H, et al. Stability of β2-microglobumin and retinol binding protein at different values of pH and temperature in normal and pathological urine [J]. Clin Chim Acta, 1990, 195 :133-138.
  • 4寇丽筠主编.临床基础检验学[M].北京:人民卫生出版社,第二版,2002,p103.
  • 5Helin I,Axenram M,Grubb A.Serum cystatin C as a determinant of glomerular filtration rate in children.Clin Nephrol,1998,49 (4):221-225.
  • 6Laterza OF,Price CP,Scott MG.Cystatin C:an improved estimator of glomerular filtration rate? Clin Chem,2002,48 (5):699-707.
  • 7NKF-DOQI工作组.王海燕,王梅,译.慢性肾脏病及透析的临床实践指南.北京:人民卫生出版社,2003.7-8.
  • 8Dickinson DP.Salivary(SD2type) cystatins:over one billion years in the marking-but to what purpose? Crit Rev Oral Biol Med,2002,13(6):485-508.
  • 9Jacobsson B,Lignelid H,Bergerheim US.Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas.Histopathology,1995,26(6):559-564.
  • 10Mendiluce A,Bustsmante J,Martin D,et al.Cystatin C as a marker of renal function in kidney transplant patients.Transplant Proc,2005,37(9):3844-3847.

共引文献87

同被引文献20

引证文献3

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部